Peiying Yang Selected Research

Lipoxygenase (Lipoxygenase-1)

1/2022	Celecoxib Colorectal Bioavailability and Chemopreventive Response in Patients with Familial Adenomatous Polyposis.
9/2016	A New Model to Study the Role of Arachidonic Acid in Colon Cancer Pathophysiology.
7/2010	Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis.
12/2006	Determination of endogenous tissue inflammation profiles by LC/MS/MS: COX- and LOX-derived bioactive lipids.
12/2005	The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis.
1/2005	Evaluation of targeted arterial delivery of the branched chain fatty acid 12-methyltetradecanoic acid as a novel therapy for solid tumors.
9/2002	Inhibition of peroxisome proliferator-activated receptor (PPAR)-mediated keratinocyte differentiation by lipoxygenase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peiying Yang Research Topics

Disease

80	Neoplasms (Cancer) 02/2022 - 09/2002
20	Carcinogenesis 01/2020 - 05/2002
17	Inflammation (Inflammations) 01/2022 - 09/2002
13	Breast Neoplasms (Breast Cancer) 07/2019 - 08/2008
9	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 05/2002
8	Lung Neoplasms (Lung Cancer) 11/2018 - 09/2002
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 09/2008
7	Carcinoma (Carcinomatosis) 01/2020 - 07/2008
7	Adenoma (Adenomas) 12/2015 - 12/2005
7	Pancreatic Neoplasms (Pancreatic Cancer) 06/2015 - 12/2007
6	Neoplasm Metastasis (Metastasis) 02/2022 - 09/2004
6	Obesity 01/2022 - 01/2011
6	Colonic Neoplasms (Colon Cancer) 01/2022 - 09/2005
6	Colorectal Neoplasms (Colorectal Cancer) 09/2020 - 07/2010
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2008 - 09/2004
4	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 11/2009
3	Body Weight (Weight, Body) 01/2022 - 08/2008
3	Polyps 01/2022 - 07/2010
3	Mouth Neoplasms (Oral Cancer) 01/2021 - 12/2006
3	Ischemic Stroke 12/2016 - 11/2011
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2020
2	Head and Neck Neoplasms (Head and Neck Cancer) 12/2019 - 09/2004
2	Triple Negative Breast Neoplasms 01/2019 - 09/2015
2	Stroke (Strokes) 12/2016 - 11/2011
2	Stomach Neoplasms (Stomach Cancer) 08/2016 - 10/2009
2	Melanoma (Melanoma, Malignant) 05/2016 - 01/2006
2	Squamous Cell Carcinoma of Head and Neck 11/2008 - 09/2004
2	Hyperplasia 11/2008 - 07/2008

Drug/Important Bio-Agent (IBA)

17	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2016 - 11/2002
16	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2002
14	Dinoprostone (PGE2)FDA Link 05/2016 - 12/2002
13	Arachidonic Acid (Vitamin F)IBA 09/2016 - 09/2002
12	EicosanoidsIBA 01/2018 - 09/2004
11	Cardiac GlycosidesIBA 01/2022 - 01/2006
11	ProstaglandinsIBA 09/2020 - 09/2002
11	EnzymesIBA 01/2020 - 11/2002
11	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 09/2016 - 09/2002
9	Pharmaceutical PreparationsIBA 01/2022 - 11/2002
9	LipidsIBA 07/2019 - 09/2004
8	oleandrinIBA 01/2022 - 01/2006
8	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2016 - 11/2002
7	PBI-05204IBA 01/2022 - 11/2011
7	Celecoxib (Celebrex)FDA Link 01/2022 - 09/2004
7	Lipoxygenase (Lipoxygenase-1)IBA 01/2022 - 09/2002
6	Biomarkers (Surrogate Marker)IBA 02/2022 - 03/2011
6	Leukotriene B4IBA 01/2022 - 09/2006
6	Caspase 3 (Caspase-3)IBA 01/2020 - 06/2003
5	AcidsIBA 01/2022 - 05/2002
5	Sulindac (Copal)FDA LinkGeneric 01/2022 - 12/2002
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 01/2008
5	Messenger RNA (mRNA)IBA 11/2018 - 03/2005
5	Prostaglandins EIBA 09/2009 - 09/2002
4	12-Hydroxy-5,8,10,14-eicosatetraenoic AcidIBA 01/2022 - 10/2007
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2020 - 02/2015
4	Eicosapentaenoic AcidIBA 01/2019 - 06/2004
4	AzoxymethaneIBA 09/2016 - 05/2008
4	Adenosine Triphosphatases (ATPase)IBA 09/2015 - 08/2009
4	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 09/2015 - 05/2008
4	15-hydroxyprostaglandin dehydrogenaseIBA 02/2015 - 09/2008
4	Protein Isoforms (Isoforms)IBA 04/2014 - 08/2008
4	Fatty Acids (Saturated Fatty Acids)IBA 03/2011 - 06/2003
4	anthraceneIBA 11/2008 - 09/2006
4	Hydroxyeicosatetraenoic Acids (HETE)IBA 10/2007 - 02/2005
3	13-hydroxy-9,11-octadecadienoic acidIBA 01/2022 - 10/2007
3	Aromatase (CYP19)IBA 01/2022 - 03/2011
3	15-hydroxy-5,8,11,13-eicosatetraenoic acidIBA 01/2022 - 01/2005
3	Biological ProductsIBA 10/2020 - 05/2002
3	huachansuIBA 08/2015 - 11/2009
3	Fish OilsIBA 07/2014 - 06/2004
3	prostaglandin E3 (PGE3)IBA 07/2014 - 01/2013
3	PPAR gammaIBA 01/2009 - 03/2005
3	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 11/2008 - 09/2006
2	salicylhydroxamic acid (SHAM)IBA 01/2022 - 12/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2011
2	Glutamine (L-Glutamine)FDA Link 01/2021 - 09/2011
2	Linoleic Acid (Linoleate)IBA 01/2020 - 09/2002
2	CholesterolIBA 01/2019 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2018 - 01/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 01/2006
2	CytokinesIBA 01/2018 - 10/2009
2	ClaudinsIBA 01/2018 - 09/2015
2	Uridine Diphosphate (UDP)IBA 12/2015 - 03/2015
2	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 12/2015 - 03/2015
2	15-keto-13,14-dihydroprostaglandin E2IBA 11/2015 - 09/2008
2	Phosphotransferases (Kinase)IBA 08/2015 - 07/2008
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2014 - 05/2008
2	LipoxygenasesIBA 10/2012 - 09/2004
2	Hormones (Hormone)IBA 10/2012 - 03/2011
2	Oxygen (Dioxygen)IBA 11/2011 - 10/2011
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2011 - 05/2011
2	bufalinIBA 03/2011 - 01/2006
2	ZyflamendIBA 11/2008 - 02/2007
2	ErbB Receptors (EGF Receptor)IBA 07/2008 - 12/2004

Therapy/Procedure

15	Therapeutics 02/2022 - 06/2003
7	Chemoprevention 01/2021 - 09/2006
5	Radiotherapy 02/2022 - 01/2017
5	Drug Therapy (Chemotherapy) 01/2021 - 02/2008
2	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 10/2012
2	Immunotherapy 06/2020 - 01/2018
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2019 - 06/2018